Children’s Hospital Colorado has become a qualified treatment center for Zevaskyn (prademagene zamikeracel), a cell-based gene therapy for…
Articles by Andrea Lobo, PhD
People living with epidermolysis bullosa (EB) generally reported that Filsuvez (birch triterpenes) had a beneficial effect on wound…
People with severe recessive dystrophic epidermolysis bullosa (RDEB) are more likely to develop disease-related complications, and at a younger…
Abeona Therapeutics is preparing for the potential launch of pz-cel (prademagene zamikeracel) to treat recessive dystrophic epidermolysis…
People with epidermolysis bullosa (EB) experience a deterioration in oral health, which is linked to poor health-related quality of…
Surgical correction followed by continuous compressive bandaging effectively treated hand finger adhesion and contractures in a woman with recessive…
RLF-TD011, an antimicrobial spray, will be granted European Union patent coverage for wound treatment in people with epidermolysis bullosa…
Three types of molecules were found to support the production of collagen VII (C7) in patient-derived cell models of recessive…
Treatment with Janus kinase (JAK) inhibitors — medications such as upadacitinib and baricitinib — was seen to work better…
About three-quarters of people with epidermolysis bullosa acquisita (EBA) treated with rituximab experienced disease remission, according to a review…
Keratinocytes, a type of skin cell, were able to restore type VII collagen (COL7) levels and improve skin integrity when…
Additional treatments following surgery for squamous cell carcinoma (SCC), a type of skin cancer, may prolong survival in people with…